| Literature DB >> 29354247 |
Mohammad Forough Reyhani1, Yousef Rezagholizadeh1, Mohammad Reza Narimani2, Lotfollah Rezagholizadeh3, Mohammad Mazani3, Mohammad Hossein Soroush Barhaghi4, Yavar Mahmoodzadeh3.
Abstract
Background. The aim of this study was to evaluate the effectiveness of different concentrations of sodium hypochlorite (NaOCl) solution in reducing bacterial growth in Enterococcus faecalis biofilms in root canals. Methods. The root canals of maxillary central incisors of 104 subjects underwent chemomechanical debridement. In order to remove the smear layer, 5.25% sodium hypochlorite solution was used for 3 minutes in the root canals. Then, the samples were immersed in 1 mL of 17% EDTA for 3 minutes. Finally, the root canals were irrigated with phosphate-buffered saline (PBS) solution. After removing the smear layer, the samples were sterilized. Then E. faecalis biofilms formed within the root canals at 4-, 6-, and 10-week intervals were evaluated. Each group was divided into 4 subgroups in terms of the antibacterial treatment: group 1: 1% NaOCl solution; group 2: 2.5% NaOCl solution; group 3: 5.25% NaOCl solution; and group 4: PBS solution. After preparation of root canal filings, the counts of live bacteria were calculated through the classic method of counting, i.e. colony forming units (CFU), followed by the analysis of data. Results. In groups 2 and 3, there was no bacterial growth due to complete removal of E. faecalis biofilms (P<0001), while the bacterial counts in group 1 at 4-, 6- and 10-week intervals decreased compared to the control group. Conclusion. The bacterial cells in mature and old biofilms have higher resistance to 1% NaOCl solution compared to the young biofilms. However, the 2.5% and 5.25% NaOCl solutions caused complete inhibition of the growth of E. faecalis biofilm in all the stages of development.Entities:
Keywords: Antibacterial; Enterococcus faecalis; biofilm; sodium hypochlorite
Year: 2017 PMID: 29354247 PMCID: PMC5768953 DOI: 10.15171/joddd.2017.038
Source DB: PubMed Journal: J Dent Res Dent Clin Dent Prospects ISSN: 2008-210X
Figure 1Descriptive statistics of colony forming units (CFU) in terms of antibacterial treatment at different incubation times
|
|
|
|
|
|
|
|
|
| 1% NaOCl | Week 4 | 3.38 | 3 | 3.11 | 1.10 | 0 | 8 |
| Week 6 | 10.63 | 10.50 | 3.37 | 1.19 | 6 | 16 | |
| Week 10 | 62.38 | 64.50 | 17.50 | 6.11 | 42 | 88 | |
| 2.5% NaOCl | Week 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Week 6 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Week 10 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5.25% NaOCl | Week 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Week 6 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Week 10 | 0 | 0 | 0 | 0 | 0 | 0 | |
| PBS | Week 4 | 18.38 | 17.50 | 4.92 | 1.74 | 11 | 26 |
| Week 6 | 73.38 | 74.5 | 14.56 | 5.14 | 48 | 91 | |
| Week 10 | 292.88 | 292.50 | 107.21 | 37.87 | 104 | 416 |
SD: Standard Deviation, SE: Standard Error, Min: Minimum, Max: Maximum
Figure 2Post hoc Tukey analysis from one-way ANOVA shows the mean differences, P-values and 95% confidence intervals of CFU/mL data between each pair of experimental groups
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
| |||||||||
|
|
| 2.73* | 0.56 | 0.000 | 4.64 | 0.825 |
| 6.31* | 0.56 | 0.000 | 8.22 | 4.40 |
|
| 7.03* | 0.56 | 0.000 | 8.95 | 5.12 |
| 15.29* | 0.56 | 0.000 | 17.20 | 13.38 | |
|
|
| 4.25* | 0.56 | 0.000 | 6.16 | 2.34 |
| 7.82* | 0.56 | 0.000 | 9.74 | 5.91 |
|
| 3.22* | 0.56 | 0.000 | 5.13 | 1.31 |
| 16.81* | 0.56 | 0.000 | 18.72 | 14.90 | |
|
| 8.55* | 0.56 | 0.000 | 10.46 | 6.64 | |||||||
|
| ||||||||||||
|
| 4.25* | 0.56 | 0.000 | 6.16 | 2.34 |
| 7.82* | 0.56 | 0.000 | 9.74 | 5.91 | |
|
| 3.22* | 0.56 | 0.000 | 5.13 | 1.31 |
| 16.81* | 0.56 | 0.000 | 18.72 | 14.90 | |
|
| 8.55* | 0.56 | 0.000 | 10.46 | 6.64 | |||||||
|
|
| 4.25* | 0.56 | 0.000 | 2.34 | 6.16 |
| 4.25* | 0.56 | 0.000 | 2.34 | 6.16 |
|
| 4.25* | 0.56 | 0.000 | 2.34 | 6.16 |
| 4.25* | 0.56 | 0.000 | 2.34 | 6.16 | |
|
| 4.30* | 0.56 | 0.000 | 6.21 | 2.39 |
| 12.56* | 0.56 | 0.000 | 14.47 | 10.64 | |
|
| 3.57* | 0.56 | 0.000 | 5.48 | 1.66 | |||||||
|
|
| 3.22* | 0.56 | 0.000 | 1.31 | 5.13 |
| 3.22* | 0.56 | 0.000 | 1.31 | 5.13 |
|
| 5.33* | 0.56 | 0.000 | 7.24 | 3.42 |
| 3.22* | 0.56 | 0.000 | 1.31 | 5.13 | |
|
| 4.60* | 0.56 | 0.000 | 6.51 | 2.69 |
| 13.56* | 0.56 | 0.000 | 15.50 | 11.67 | |
|
|
| 3.22* | 0.56 | 0.000 | 5.13 | 1.31 |
| 7.82* | 0.56 | 0.000 | 9.74 | 5.91 |
|
| 8.55* | 0.56 | 0.000 | 10.46 | 6.64 |
| 16.81* | 0.56 | 0.000 | 18.72 | 14.90 | |
|
|
| 8.55* | 0.56 | 0.000 | 10.64 | 6.64 |
| 16.81* | 0.56 | 0.000 | 18.72 | 14.90 |
|
| 7.82* | 0.56 | 0.000 | 9.74 | 5.91 | |||||||
|
|
| 8.55* | 0.56 | 0.000 | 6.64 | 10.46 |
| 8.25* | 0.56 | 0.000 | 10.16 | 6.34 |
|
| 8.55* | 0.56 | 0.000 | 6.64 | 10.46 | |||||||
|
|
| 7.82* | 0.56 | 0.000 | 5.91 | 9.74 |
| 8.98* | 0.56 | 0.000 | 10.89 | 7.07 |
|
| 7.82* | 0.56 | 0.000 | 5.91 | 9.74 | |||||||
|
|
| 16.81* | 0.56 | 0.000 | 18.27 | 14.90 | ||||||
|
|
| 16.81* | 0.56 | 0.000 | 17.27 | 14.90 | ||||||
A. 1% Sodium hypochlorite (NaOCl) at week 4; B. 2.5% NaOCl at week 4; C. 5.25% NaOCl at week 4; D. Phosphate buffer saline (PBS) at week 4; E. 1% NaOCl at week 6; F. 2.5% NaOCl at week 6; G. 5.25% NaOCl at week 6; H. PBS at week 6; I. 1% NaOCl at week 10; J. 2.5% NaOCl at week 10; K. 5.25% NaOCl at week 10; L. PBS at week 10.